Pfizer Animal Health

Get more information about a specific species.


VANGUARD® PLUS CPV
Injectable

Description

  • VANGUARD® PLUS CPV is a liquid preparation of a high-titer, modified-live canine parvovirus (CPV) strain attenuated by low passage on an established canine cell line. The combination of high titer and low passage gives VANUGUARD PLUS CPV immunogenicity capable of overriding appreciable levels of maternal CPV antibodies in puppies 6 weeks of age or older.
Approved Uses

VANGUARD PLUS CPV is approved for:
  • Vaccination of healthy dogs for the prevention of canine parvoviral enteritis caused by canine parvovirus.
Key Features

  • Inherently greater immunogenicity of a low-passage CPV vaccine produced at high titer can stimulate active immunity in the presence of maternal antibodies. Serum neutralization titers as low as 1:4 can prevent active immunization by conventional vaccines. VANGUARD PLUS CPV has been shown to successfully immunize dogs with prevaccination serum neutralization (SN) titers, some as high as 1:64


  • Customer-friendly packaging using recycled materials includes peel-off labels to make record-keeping faster and more accurate, a color-coded organizing system, and an easy-open safety band.
Packaging

25 x 1-dose vials.

Dosage and Administration

  • General directions: Vaccination of healthy dogs is recommended. Shake well. Aseptically administer a 1 mL dose subcutaneously or intramuscularly.


  • Primary vaccination: Puppies 6 weeks of age or older should receive 3 doses, each given 3 weeks apart.


  • Revaccination: Annual revaccination with a single dose is recommended.
Precautions

  • Store at 2°–7° C. Prolonged exposure to higher temperature and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used. Burn containers and all unused contents.


  • As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy. These products have been shown to be efficacious in healthy animals. A protective immune response may not develop if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or if the vaccine is not administered according to label directions.


  • For use in dogs only.


  • Vaccination of pregnant bitches should be avoided.


  • For veterinary use only.

Product Information

Back to top

entire article (printer friendly)

Locate a Product

Use the menus below to find product information.

 View all PfizerAH Dogs products

Locate a Product

There are no scheduled
events listed at this time.

Search
 
Advanced Search




Copyright © 2010 Pfizer Inc. All rights reserved.


The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.